Premium European CRO focused on complex cardiovascular, TAVI, and structural heart devices[cite: 5, 6, 41]. Led by Former Notified Body Reviewers, we design studies exactly the way regulators expect to see them[cite: 8, 9].
Eclevar MedTech's expertise is built on a senior team combining medical vision, regulatory mastery, and clinical data governance.
Expert in data governance and clinical data management.
Senior project strategy and clinical operations lead.
Operational specialist for complex cardiovascular trials.
A key differentiator of ECLEVAR MEDTECH is our expertise in structuring IIS and indication expansion programs, particularly for complex cardiovascular and structural heart devices.
Full clinical support for high-risk and non-surgical patient populations. Design of strategic evidence generation for transcatheter aortic valves with complex endpoints.
Evidence generation for coronary and peripheral guidewires. Collection of high-quality clinical data sets to ensure regulatory success in European markets.
Clinical programs designed with regulatory review in mind. We understand how a reviewer thinks because our leadership comes from within the Notified Bodies.
Anticipation of Ethics and Regulatory file requirements for complex programs, ensuring every dataset is "regulator-usable" from day one.
Rigorous management of safety data and endpoints, essential for high-risk cardiovascular devices and structural heart interventions.
Global standards with a "boutique" approach. We provide deep focus on TAVI, structural heart, and guidewire trials with unmatched precision.
Strategic clinical expertise combined with deep local execution through our dedicated team of CRAs on the ground.
Whether you are developing a TAVI system, a structural heart device, or planning indications expansion, ECLEVAR MEDTECH can support you with a consistent, regulator-ready clinical strategy.
Guaranteed response time within 24 hours.
